Drug
ZOMACTON
ZOMACTON is a pharmaceutical drug with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
2(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (100.0%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
terminated
Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
NCT03274973
completedphase_3
A Study of Zomacton in Children With Growth Hormone Deficiency
NCT00884000
completedphase_3
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
NCT00250250
Clinical Trials (3)
Showing 3 of 3 trials
NCT03274973
Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
NCT00884000Phase 3
A Study of Zomacton in Children With Growth Hormone Deficiency
NCT00250250Phase 3
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3